Pricing Log in Create free account

LeonaBio, Inc. (LONA) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)

LeonaBio, Inc. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. LeonaBio, Inc. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($49.8M and $49.3M). Across the 8 metrics below, Mereo BioPharma Group plc - Sponsored ADR leads on 5 and LeonaBio, Inc. on 3.

Valuation

Metric LONA MREO Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 3.67 1.68 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (444.41%) (58.20%) (33.15%)
Free cash flow yield (50.22%) (53.23%) (25.50%)

Profitability

Metric LONA MREO Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (431.39%) (67.85%) (56.36%)
Return on assets (306.05%) (57.73%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LONA MREO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 1.98% 10.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LONA MREO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.01 5.88 4.72
Net debt to EBITDA 0.87 1.04 0.96

Dividend

Metric LONA MREO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LONA MREO Biotechnology median
Market cap 49.84m 49.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack